Work

Human vaccines and immunotherapeutics: News July 2024

Year: 2024

Type: editorial

Abstract: First-line treatment with the interleukin-12 immunotherapeutic IMNN-001 (Imunon) and chemotherapy extended median overall survival in patients with advanced ovarian cancer by 11 months, compared to...

Source: Human Vaccines & Immunotherapeutics

DOI: 10.1080/21645515.2024.2389022

Authors: Ronald Ellis, Adam Weiss

Institution: Taylor and Francis (United Kingdom)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,175

OpenAlex ID: W4401567565

Cites: 1

Cited by:

Related to: 10